Search Results - "Marampon, Francesco"
-
1
Strategies for Bone Regeneration: From Graft to Tissue Engineering
Published in International journal of molecular sciences (23-01-2021)“…Bone is a regenerative organ characterized by self-renewal ability. Indeed, it is a very dynamic tissue subjected to continuous remodeling in order to preserve…”
Get full text
Journal Article -
2
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
Published in International journal of molecular sciences (23-05-2019)“…ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating…”
Get full text
Journal Article -
3
Bone Control of Muscle Function
Published in International journal of molecular sciences (11-02-2020)“…Bone and muscle represent a single functional system and are tightly connected to each other. Indeed, diseases characterized by alterations of muscle…”
Get full text
Journal Article -
4
New Insights on the Nuclear Functions and Targeting of FAK in Cancer
Published in International journal of molecular sciences (11-02-2022)“…Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed and activated in both adult and pediatric cancers, where it plays important roles…”
Get full text
Journal Article -
5
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
Published in International journal of molecular sciences (31-01-2023)“…Oral squamous cell carcinoma (OSCC) is a rapidly progressive cancer that often develops resistance against DNA damage inducers, such as radiotherapy and…”
Get full text
Journal Article -
6
Cellular and Molecular Mediators of Bone Metastatic Lesions
Published in International journal of molecular sciences (08-06-2018)“…Bone is the preferential site of metastasis for breast and prostate tumor. Cancer cells establish a tight relationship with the host tissue, secreting factors…”
Get full text
Journal Article -
7
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation
Published in Cancer letters (01-05-2019)“…Rhabdomyosarcoma (RMS) is a pediatric soft tissue tumor classified in two major subtypes namely embryonal and alveolar, which have distinctive…”
Get full text
Journal Article -
8
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
Published in Molecular cancer (20-02-2016)“…The identification of signaling pathways that affect the cancer stem-like phenotype may provide insights into therapeutic targets for combating embryonal…”
Get full text
Journal Article -
9
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
Published in International journal of molecular sciences (01-10-2021)“…Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood. About 25% of RMS expresses fusion oncoproteins such as PAX3/PAX7-FOXO1…”
Get full text
Journal Article -
10
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
Published in Molecular cancer (25-11-2010)“…Epigenetic modifications play a key role in the patho-physiology of many tumors and the current use of agents targeting epigenetic changes has become a topic…”
Get full text
Journal Article -
11
The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
Published in International journal of molecular sciences (01-09-2022)“…The prostacyclin analogue iloprost is used to treat vascular alterations and digital ulcers, the early derangements manifesting in systemic sclerosis (SSc), an…”
Get full text
Journal Article -
12
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov
Published in Radiation oncology (London, England) (04-04-2023)“…The management of brain metastases (BM), the major cause of cancer morbidity and mortality, is becoming an emerging area of interest. Surgery, whole brain…”
Get full text
Journal Article -
13
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
Published in International journal of molecular sciences (31-10-2022)“…Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence that includes FP-RMS, harboring the fusion oncoprotein PAX3/7-FOXO1…”
Get full text
Journal Article -
14
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma
Published in BMC cancer (08-07-2024)“…Despite a multimodal approach including surgery, chemo- and radiotherapy, the 5-year event-free survival rate for rhabdomyosarcoma (RMS), the most common soft…”
Get full text
Journal Article -
15
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Published in Journal of hematology and oncology (05-01-2017)“…Glioblastoma recurrence after treatment with the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab is characterized by a highly infiltrative…”
Get full text
Journal Article -
16
Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
Published in International journal of molecular sciences (12-03-2021)“…Skeletal muscle damage is a common clinical manifestation of systemic sclerosis (SSc). C-X-C chemokine ligand 10 (CXCL10) is involved in myopathy and…”
Get full text
Journal Article -
17
Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients
Published in PloS one (23-06-2015)“…aim of this study was to identify outcomes in pain relief and quality of life in patients with a solitary painful osseous metastasis treated by radiotherapy,…”
Get full text
Journal Article -
18
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines
Published in Cancer letters (01-10-2019)“…This study describes the in vitro and in vivo activity of PXD-101 (Belinostat), a novel hydroxamic acid-type pan-HDACs inhibitor characterized by a larger…”
Get full text
Journal Article -
19
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
Published in Journal of cancer research and clinical oncology (01-01-2019)“…Purpose PARP inhibitors (PARPi) are used in a wide range of human solid tumours but a limited evidence is reported in rhabdomyosarcoma (RMS), the most frequent…”
Get full text
Journal Article -
20
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
Published in Pharmaceuticals (Basel, Switzerland) (14-11-2020)“…Schizophrenia was first described by Emil Krapelin in the 19th century as one of the major mental illnesses causing disability worldwide. Since the…”
Get full text
Journal Article